Czechia· CZ-0013506

INDIVINA

A medroxyprogesteron und estrogen product containing estradiol valerate + medroxyprogesterone acetate, registered in Czechia by Orion Corporation, Espoo. The same ATC class is registered in 5 of our 19 countries.

ATC G03FA12

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedINDIVINAATCG03FA12REGISTER NO.CZ-0013506PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Medroxyprogesteron und estrogen is registered in 5 of 19 countries.

Countries holding a registration under ATC G03FA12 (medroxyprogesteron und estrogen), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 4 of them publish a price we can compare per daily dose

Medroxyprogesteron und estrogen · ATC G03FA12

5 / 19 countries

  • Czechiaprice
  • Denmark
  • Finlandprice
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
ESTRADIOL VALERATE + MEDROXYPROGESTERONE ACETATE
Manufacturer
Orion Corporation, Espoo
Country
Czechia (CZ)
ATC code
G03FA12
ATC class
Medroxyprogesteron und Estrogen
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

11 interactions on record for medroxyprogesteron und estrogen.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Medroxyprogesteron und estrogen · interactions on record

11 records

11 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Medroxyprogesteron und estrogen in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All medroxyprogesteron und estrogen products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Germany · Indivina
  • Denmark · Indivina
  • Finland · Indivina
  • France · Duova
  • United Kingdom (Northern Ireland) · Indivina
  • Norway · Indivina
  • Sweden · Indivina

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5d0c813b-a3d2-4619-bfd3-b532d868e92b
GET /v1/drugs/5d0c813b-a3d2-4619-bfd3-b532d868e92b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL NOB",
  "source": "sukl",
  "strength": "2MG/5MG",
  "pack_size": "1X28",
  "substance": "ESTRADIOL VALERATE + MEDROXYPROGESTERONE ACETATE",
  "cz_kod_sukl": "0013506",
  "product_type": "CH",
  "substance_codes": "564,882",
  "registration_state": "R",
  "registration_number": "56/492/00-C"
}

See everything about medroxyprogesteron und estrogen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.